Abbott
Laboratories, Inc., Abbott Park, Illinois
Aphios
Corporation has isolated and purified pilot quantities of
a taxols intermediate, 9-dihydro-13-acetylbaccatin III (9-DHAB),
for Abbott Laboratories, Inc., Abbott Park, Illinois.
Abbott
Laboratories is a global, diversified health care company
devoted to the discovery, development, manufacture and marketing
of pharmaceutical, diagnostic, nutritional and hospital products.
The company employs 56,000 people and markets its products
in more than 130 countries. In 1998, the company’s sales
and net earnings were $12.5 billion and $2.3 billion, respectively,
with diluted earnings per share of $1.51. Abbott Laboratories
has been in the business of improving lives for more than
a century and is dedicated to discovering, developing and
marketing innovative health care solutions across the spectrum
of health care. (www.abbott.com).
Home
l Company | Infectious
Diseases | Oncology | Nutraceuticals
| Product Pipeline | Purchase
Products | Technology Platforms
| Equipment |Patents
| Press
Releases | Contact Aphios
©1999-
2007 Aphios® Corporation
All rights reserved
|